entertainment -WSS

entertainment

author：comprehensive 2025-09-29 19:05:06 - browse：91287

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： FDA gives detailed accounting of AI

leisure time

WSS

Eli Lilly expects to double planned employment in Boston center

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Boeing's 1st astronaut flight bumped into next year, more repairs needed

FDA struggles to regulate food additives, sometimes for decades

First Opinion Podcast: Long Covid needs a new approach

Studies point to risks of excluding people with obesity from drug trials

focus

entertainment

leisure time

Hollywood unions extend contract negotiations for actors

Impact of Dobbs ruling felt at reproductive medicine meeting

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

United colonoscopy coverage change 'may cost lives,' doctors say

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Heart attack and stroke risk calculators need revising

Pharmacists can make shortage drugs, but at what cost?

New air purifier tech could be key to improving indoor air quality

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Wikipedia

The EU Joint Clinical Assessment needs to live up to its promise

Senate committee scrutinizes Medicare Advantage brokers

Illinois to ban advertising for guns allegedly marketed to kids and militants

The explosion of genetic testing requires a new approach

The UK government moves asylum

UnitedHealth’s board chair also owns a personal investment firm

hotspot

leisure time

explore

hotspot